A 28.7% average weight loss at 68 weeks coupled with transformative improvements in knee osteoarthritis pain, cardiovascular risk markers, and metabolic health represents a genuine advance in obesity treatment
Novo Nordisk filed for FDA approval of CagriSema in early 2026, with a review decision expected later this year
defends against oxidative stress while supporting mitochondrial longevity
Studying them in isolation leaves combinatorial dynamics and potential synergistic signaling patterns unexplored, which is a meaningful limitation when the research question involves multi-tissue or systemic repair contexts
Circular RNAs are miRNA sponges and can be used as a new class of biomarker
The company has sued at least two other former employees in Harris County, alleging they too shared confidential company information with competitors, records show